Analytical Data
-
基因名
DCTN3
- Application
-
别名
Dynactin complex subunit 22KDA subunit ;p22
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O75935
-
表达区间
2-176aa
-
分子量
35.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DCTN3, or Dynactin subunit 3, is a critical component of the dynactin complex, which plays a pivotal role in intracellular transport, particularly in the movement of organelles, vesicles, and chromosomes. Research on DCTN3 has garnered interest due to its significant involvement in cellular processes and its potential implications in neurodegenerative diseases and cancer. Mutations or dysregulation of DCTN3 have been associated with various pathological conditions, highlighting its importance in maintaining cellular health and function. The study of recombinant DCTN3 protein allows researchers to investigate its structure, function, and interactions with other cellular molecules in vitro. This research can provide insights into the molecular mechanisms underlying cellular transport and reveal how alterations in DCTN3 activity may contribute to disease states. Additionally, understanding the functional dynamics of DCTN3 through recombinant protein studies can pave the way for developing therapeutic strategies targeting dynactin-related pathways. Overall, the exploration of DCTN3 and its recombinant protein lays the groundwork for elucidating the complexities of cellular transport mechanisms and their relevance in health and disease.
